Breaking Down WGSN’s Consumer Marketing Insights from Cannes Lions

 

Cannes Lions is where creative excellence shines. The International Festival of Creativity, held since 1954, is where the world’s top-ranking agencies, brands, and creatives gather to share and collaborate. After a two-year festival hiatus due to the Covid-19 pandemic, the Cannes Lions roared again.

WGSN, a leader in consumer insights, was there at the festival to learn more. So, what has the industry been up to that will help shape the future? 

Joe McDonnell, Director of WGSN Insight, attended the conference and provided host Christine Russo, host of What Just Happened?, with a ringside seat to all the happenings of the festival and the fantastic creative consumer marketing trends making headways. One brand trend is the utilization of virtual ambassadors or digital influencers/avatars to launch their campaigns globally. 

Russo and McDonnell touch on several highlights from Cannes Lions: 

  • The strategy behind brands utilizing virtual influencers 
  • The role AI plays in creating and deploying virtual influencers 
  • How the creatives campaigns and ideas relate to commerce  

“It’s about trying to join the dots between everything from data through the culture,” McDonell said. “Seeing something inspirational, whether it’s a session or a piece of work, thinking that model or that piece of tech, or that consumer insight is exactly what we need in our business or with our clients.” 

McDonnell is an experienced marketing, communications, content, and partnership leader. As the current Director of Insight at WGSN, the world’s most prominent trend forecaster, McDonnell’s responsibilities include managing a team of 17 experts who create strategic content and research exploring innovations across the marketing, consumer, retail, gaming, and innovations space.

McDonnell provides expert commentary as a forecaster for the BBC, Bloomberg, Telegraph, Times, Guardian, US Chamber of Commerce, CGTV, Vogue, and WARC, while also being a keynote speaker at Cannes Lions, Outdoor Retailer, and SXSW. 

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More